Learn how researchers conducted a qualitative study to explore how boxed warnings (BWs) fit within health care providers (HCPs) overall treatment decision-making, and how HCPs communicate with patients about BWs in the latest Spotlight on CDER Science: https://lnkd.in/gmwBgBxE
About us
The Food and Drug Administration is an agency within the Department of Health and Human Services. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. FDA also has responsibility for regulating the manufacturing, marketing, and distribution of tobacco products to protect the public health and to reduce tobacco use by minors. FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. FDA also plays a significant role in the Nation's counterterrorism capability. FDA fulfills this responsibility by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats.
- Website
-
http://www.fda.gov/
External link for FDA
- Industry
- Government Administration
- Company size
- 10,001+ employees
- Headquarters
- Silver Spring, MD
- Type
- Government Agency
- Specialties
- Food, Drugs, Medical Devices, Vaccines Blood and Biologics, Animal and Veterinary, Cosmetics, Radiation-Emitting Products, Tobacco Products, Regulatory Research, and Toxicological Regulatory Research
Locations
-
Primary
10903 New Hampshire Ave
Silver Spring, MD 20993, US
Employees at FDA
Updates
-
Join the FDA Oncology Center of Excellence for the first National Hispanic/Latino Family Cancer Awareness Week! ✨ September 20-26, 2004 ¡Únase al Centro de Excelencia en Oncología de la Administración de Alimentos y Medicamentos de los Estados Unidos para la primera Semana Nacional de Concientización sobre el Cáncer en las Familias Hispanas/Latinas! ✨ 20 al 26 de septiembre de 2024 Register and virtually attend the Oncology Center of Excellence Conversation on Cancer public discussion. https://lnkd.in/dNE5eU_U Regístrese y asista virtualmente a la conversación pública sobre el cáncer en el Centro de Excelencia en Oncología. https://lnkd.in/ebr_gk32 More information: https://lnkd.in/dM4NSjFd Información adicional: https://lnkd.in/dR7R-acz #LatinoCancer #OCEProjectCommunity #HHM24
-
-
SAVE THE DATE: We’re hosting a Medical Device Sterilization Town Hall: Sterility Master Files and Effective Use in Premarket Submissions on September 11, 2024. Join us from 1-2 p.m. (ET). Learn more: https://lnkd.in/eM3etqVi
-
-
FDA continues to announce Human Foods Program Title 21 career opportunities. Be part of the FDA’s HFP mission-driven team and help protect the nation’s food supply. Applications for these positions are open through October 2, 2024: ▪ Office Director, Office of Communications, Education, and Engagement (OCEE) ▪ Office Director, Office of Quality Assessment and Management (OQAM) For more information on these positions and how to apply, please visit: https://lnkd.in/eRtwmFPw Bookmark this page for future HFP opportunities! FDA has an ongoing need for qualified individuals with backgrounds in biology, microbiology, chemistry, toxicology and other health-related sciences, data science, food safety, nutrition, health policy, health communications, quality assurance, and regulatory counsel as well as other professional and administrative fields. #hiring #jobopenings #healthcommunications #foodscientists
-
-
The FDA is Chair and Secretariat of the International Medical Device Regulators Forum in 2024. IMDRF develops internationally agreed upon documents related to a variety of topics affecting #MedicalDevices. Learn more: https://lnkd.in/eUstpZNC
-
-
Step into the forefront of novel endpoint development for #RareDisease #DrugDevelopment! CBER invites you to submit a #Proposal to the #RareDisease Endpoint Advancement (RDEA) Pilot Program, a collaboration with @FDA_Drug_Info. Deadline is 9/30/24! bit.ly/48UBUx4
-
Substance use can impact anyone. 🎧 Listen to our podcast with Dr. Marta Sokolowska discussing naloxone and nalmefene nasal sprays, medications for opioid overdose: https://lnkd.in/eSQ3grBM 📝 Sign up for our Controlled Substances Program updates: https://lnkd.in/ezU2fj3H 💊 Learn more about how to prescribe medications for opioid use disorder: https://lnkd.in/gijcQBrP #OverdoseAware
-
Today, we granted emergency use authorization for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. https://lnkd.in/eURWEUTU The updated vaccine is authorized for use in individuals 12 years of age and older. It includes a monovalent (single) component that corresponds to the Omicron variant JN.1 strain of SARS-CoV-2. This authorization follows the FDA’s recent approvals and authorizations of updated mRNA COVID-19 vaccines for 2024-2025 manufactured by ModernaTX Inc. and Pfizer Inc.
-
-
⚠️ Today is the last day to request to speak at our 9/20 meeting focusing on patient perspectives on safety considerations for approved #genetherapy treatments for rare diseases & long-term studies. We want to hear from you! Register & request to speak ➡️ https://bit.ly/3XUEQrP
-